Gad Getz

Gad Getz

Harvard University

H-index: 228

North America-United States

About Gad Getz

Gad Getz, With an exceptional h-index of 228 and a recent h-index of 197 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cancer Genomics, Computational Biology, Bioinformatics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Inferring early genetic progression in cancers with unobtainable premalignant disease

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

Polymorphic gene typing and somatic change detection using sequencing data

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology

The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia

Proteogenomic data and resources for pan-cancer analysis

Gad Getz Information

University

Position

Massachusetts General Hospital and Broad Institute of Harvard and MIT

Citations(all)

342986

Citations(since 2020)

208304

Cited By

219935

hIndex(all)

228

hIndex(since 2020)

197

i10Index(all)

387

i10Index(since 2020)

368

Email

University Profile Page

Google Scholar

Gad Getz Skills & Research Interests

Cancer Genomics

Computational Biology

Bioinformatics

Top articles of Gad Getz

Inferring early genetic progression in cancers with unobtainable premalignant disease

Nature Cancer

2023/4

Polymorphic gene typing and somatic change detection using sequencing data

2023/8/15

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

Blood cancer discovery

2023/3/1

MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology

Cancer discovery

2023/2/6

The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia

Blood Advances

2023/1/10

CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers

Science

2023/8/4

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

Blood

2023/8/3

Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy

Nature Cancer

2023/8

Gad Getz
Gad Getz

H-Index: 174

Jack Bartram
Jack Bartram

H-Index: 15

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

Blood Advances

2023/7/28

Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors

Clinical Cancer Research

2023/6/13

Gad Getz
Gad Getz

H-Index: 174

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

Blood Advances

2023/5/9

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Nature genetics

2022/11

AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer.

Cancer discovery

2022/11/2

Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 …

JAMA oncology

2022/8/1

See List of Professors in Gad Getz University(Harvard University)

Co-Authors

academic-engine